- Home
- PLSE vs CET Comparison
PLSE vs CET Comparison
Compare PLSE & CET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLSE | CET |
|---|---|---|
| Founded | 2014 | 1929 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | PLSE | CET |
|---|---|---|
| Price | $24.09 | $53.14 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $22.00 | N/A |
| AVG Volume (30 Days) | ★ 362.2K | 31.6K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.12% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $840.00 | N/A |
| Revenue Next Year | $287.54 | N/A |
| P/E Ratio | ★ N/A | $6.93 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.56 | $46.47 |
| 52 Week High | $27.98 | $54.28 |
Technical Indicators
Market Signals| Indicator | PLSE | CET |
|---|---|---|
| Relative Strength Index (RSI) | 53.22 | 52.75 |
| Support Level | $17.58 | $50.76 |
| Resistance Level | $27.14 | $53.97 |
| Average True Range (ATR) | 1.89 | 0.71 |
| MACD | -0.02 | -0.06 |
| Stochastic Oscillator | 49.24 | 47.24 |
Price Performance
Historical ComparisonAbout PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
About CET Central Securities Corporation
Central Securities Corp is a non-diversified closed-end management investment company. The company's investment objective is long-term growth of capital. It invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.